FBXO5 and colorectal carcinoma: To assess the impact reduced EMI1 expression has on CIN, we coupled transient siRNA-based silencing and QuantIM in HCT116, a male, karyotypically stable malignant CRC cell line used extensively in previous CIN studies [17, 23, 36, 39].